Krystal Biotech, Inc. <KRYS.O>: RBC Initiates Coverage With Outperform Rating; Target Price $400
KRYS•Related News
Live Markets-That's why AI is going to be inflationary in the short-term
SPY•
Americas Gold and Silver Q2 Revenue USD 46 Million
USAS•
Sands China FY26 H1 profit falls 3.6% to US$398 million; net revenues rise 11.1% to US$3.88 billion
LVS•
LyondellBasell declares $0.69 quarterly dividend per share
LYB•
Celcuity Inc. <CELC.O>: Stifel cuts target price to $150 from $175
CELC•